ABIN362922
antibody from antibodies-online
Targeting: MAPK14
CSBP1, CSBP2, CSPB1, Mxi2, p38, PRKM14, PRKM15
Antibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN362922 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Mitogen-Activated Protein Kinase 14 (MAPK14) (AA 180-184) antibody
- Antibody type
- Polyclonal
- Antigen
- Peptide sequence around AA 180-184 (T-G-Y-V-A) derived from Human P38 MAPK. Antibodies were produced by immunizing rabbits with synthetic peptide and KLH conjugates.
- Description
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography usingepitope-specific immunogen. Specificity/Sensitivity P38MAPK (Ab-182) antibody detects endogenous levels of total P38MAPK protein.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Epitope
- AA 180-184
- Isotype
- IgG
- Vial size
- 100 μL
- Concentration
- 1 mg/mL
- Storage
- Store at -20°C for long term preservation (recommended). Store at 4°C for short term use.
Submitted references Intracellular acidosis-activated p38 MAPK signaling and its essential role in cardiomyocyte hypoxic injury.
p38 mitogen-activated protein kinase inhibition increases cytokine release by macrophages in vitro and during infection in vivo.
Zheng M, Reynolds C, Jo SH, Wersto R, Han Q, Xiao RP
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2005 Jan;19(1):109-11
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2005 Jan;19(1):109-11
p38 mitogen-activated protein kinase inhibition increases cytokine release by macrophages in vitro and during infection in vivo.
van den Blink B, Juffermans NP, ten Hove T, Schultz MJ, van Deventer SJ, van der Poll T, Peppelenbosch MP
Journal of immunology (Baltimore, Md. : 1950) 2001 Jan 1;166(1):582-7
Journal of immunology (Baltimore, Md. : 1950) 2001 Jan 1;166(1):582-7
No comments: Submit comment
No validations: Submit validation data